InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by STARR KEVIN P, Director. Insider active across 1 companies, notably Sage Therapeutics, Inc.. In total, 2 disclosures have been logged. Total volume traded: €1.7m. The latest transaction was disclosed on 16 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€833,62617,842 shares@ €46.7227100.0% of flow
Common Stock
SEC:0001562180-21-004343·
Ideal exit: 13 Mar 2022 (T+270)
€833,62617,842 shares@ €46.722750.0% of flow
Common Stock
SEC:0001562180-21-004343:0·
Ideal exit: 13 Mar 2022 (T+270)
2 of 2 declarations
About STARR KEVIN P
Kevin P. Starr is a Board Member at Sage Therapeutics, Inc. He plays a key role in the strategic direction of the company, ensuring it adheres to best practices in governance. His experience in the healthcare sector is an asset for innovation initiatives.
